Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:26 2024-04-24 am EDT 5-day change 1st Jan Change
152.4 EUR -0.85% Intraday chart for Merck KGaA +0.83% +5.73%
Sales 2024 * 21.25B 22.73B Sales 2025 * 22.5B 24.07B Capitalization 66.24B 70.86B
Net income 2024 * 2.97B 3.18B Net income 2025 * 3.48B 3.72B EV / Sales 2024 * 3.44 x
Net Debt 2024 * 6.79B 7.26B Net Debt 2025 * 4.83B 5.17B EV / Sales 2025 * 3.16 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
19 x
Employees 62,908
Yield 2024 *
1.52%
Yield 2025 *
1.59%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.85%
1 week+0.83%
Current month-6.88%
1 month-5.84%
3 months+2.39%
6 months+5.18%
Current year+5.73%
More quotes
1 week
142.70
Extreme 142.7
155.60
1 month
142.70
Extreme 142.7
164.85
Current year
140.50
Extreme 140.5
164.85
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
59.33
Extreme 59.325
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Chairman 67 19-04-25
Director/Board Member 61 12-04-30
More insiders
Date Price Change Volume
24-04-24 152.4 -0.85% 339,364
24-04-23 153.6 +4.03% 503,255
24-04-22 147.7 +1.16% 214,993
24-04-19 146 -0.51% 353,173
24-04-18 146.8 -0.31% 511,371

Delayed Quote Xetra, April 24, 2024 at 11:35 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
152.4 EUR
Average target price
182 EUR
Spread / Average Target
+19.46%
Consensus